Stock Investing - StockBaggers.com

MEDX Stock Investing

StockBagger Expert — Fri, 27 Jul 2007 13:01:01 +0000

Medarex Announces Advancement of Antibody Development by Partner (PR Newswire)Medarex, Inc. announced today that its partner MedImmune, Inc. has initiated a Phase Ib multi-dose clinical trial of MEDI-545 for the potential treatment of systemic lupus erythematosus .

Board change at Vanda Pharmaceuticals (bizjournals.com)Venture capitalist Jim Tananbaum has resigned from the board of Vanda Pharmaceuticals Inc., where he has served as a director since 2004.

Vanda Names New Board Member (AP)Biopharmaceutical company Vanda Pharmaceuticals Inc. said Tuesday it named Howard H. Pien to replace James B. Tananbaum on the company’s board.

Melanoma Therapy From Medarex May Be Next Big Thing (Investor’s Business Daily)Melanoma accounts for just 3% of all skin cancers, but it’s the deadliest. The American Cancer Society expects melanoma to afflict nearly 60,000.

The “Naked” Truth About Antibodies For Cancer Therapy (Seeking Alpha)Ohad Hammer submits: Antibodies are naturally occurring proteins that help our body fight bacteria, viruses and cancer. Upon its release into the blood stream, an antibody can identify and bind a specific pathogen, and by doing so, it can neutralize the pathogen or flag it for attack by the immune system.

Healthcare Acquisition Corp. Announces Special Meeting of Stockholders to Vote on Proposed Merger With PharmAthene and Announces Mailing of Proxies to Stockholders of Record (PR Newswire)Healthcare Acquisition Corp. , a publicly-traded special purpose acquisition company, announced that it has scheduled a special meeting of its stockholders to vote on, among other things, the proposed merger transaction with PharmAthene, Inc., a biodefense company developing and commercializing medical countermeasures against biological and chemical threats.

MEDX Stock Investing | Google Finance MEDX | Yahoo Finance MEDX

HRB Stock Investing

StockBagger Expert — Fri, 27 Jul 2007 13:00:59 +0000

H&R Block CEO’s 2007 Pay $3.1 Million (AP)Mark Ernst, H&R Block Inc.’s top executive, received compensation during fiscal year 2007 valued at $3.1 million, according to a proxy statement the tax preparer filed Thursday.

Mortgage Applications Fall (AP)Applications for U.S. home mortgages fell last week as the housing market continued to struggle, an industry group said Wednesday.

Wells Fargo pulls popular subprime loan from mix (Reuters)Wells Fargo & Co., the fifth-largest U.S. bank, on Monday said it stopped offering a popular subprime mortgage product in response to market and regulatory pressure.

H&R Block Gets Time for Subprime (AP)A number of lenders will continue to fund H&R Block’s troubled subprime mortgage arm until it can be sold later this year, according to regulatory documents filed Friday by the tax preparation company.

HRB Stock Investing | Google Finance HRB | Yahoo Finance HRB

Where to stash your everyday cash

StockBagger Expert — Fri, 27 Jul 2007 13:00:51 +0000

Home Builders Post Steep Losses as Value of Unsold Land SlipsD. R. Horton and Beazer Homes USA, two large home builders, saw losses in the last quarter and predicted more tough times to come.

Dow falls 311 points on housing, credit fearsThe market’s worst loss since February comes on worries about housing, credit markets contraction and ExxonMobil’s disappointing earnings report. Apple’s earnings shine; Ford surprises with a profit. Is the end of the leveraged-buyout era here?

Where to stash your everyday cashOnline competition is pressuring traditional banks and brokerages to offer higher interest rates on savings, money-market and checking accounts. Here’s how they compare with Internet-based banks.

Japanese stocks down; dollar unchanged (AP)

AP - Japanese stocks fell for a second day Thursday as investors remained cautious ahead of the upper house elections Sunday and amid a flurry of corporate earnings reports.

S&P, Nasdaq slip in volatile session (FT.com)FT.com - Wall Street stocks turned mixed in afternoon trading on Wednesday as investors responded to generally upbeat company earnings from companies including Amazon and Boeing (NYSE:BA) and got to grips with fresh housing market data.

Economic growth rebounds in second quarterWASHINGTON (Reuters) - Economic growth rebounded during the second quarter to its strongest pace since the beginning of last year on a surge in business investment, more government spending and a better trade performance, the Commerce Department reported on Friday.

Stock Investing

JNJ Stock Investing

StockBagger Expert — Fri, 27 Jul 2007 13:00:46 +0000

Contract costs sock Convergys’ 2Q earnings (bizjournals.com)Shares of Convergys Corp. stock plummeted more than 14 percent in trading Wednesday amid weaker-than-expected second-quarter earnings.

Siemens to buy Dade, fuels hopes for Beckman bid (Reuters)The $6.3 billion takeover bid for Dade Behring Holdings Inc. by Siemens AG , the latest deal in the hot clinical diagnostic business, is lifting shares of Dade rival Beckman Coulter Inc. amid expectations it too will get an offer, analysts said on Wednesday.

Asset Allocation for Retirement (Motley Fool)Simple rules for any time horizon.

Amgen Sees Slow Sales Growth (AP)Biotech giant Amgen Inc. reported slow revenue growth on Thursday but managed to beat Wall Street estimates for the second quarter after taking nearly $300 million in one-time charges.

Ahead of the Bell: Glaxo’s Avandia (AP)Government documents due out Thursday will give Wall Street the latest indication of whether GlaxoSmithKline’s blockbuster diabetes drug Avandia is headed for new regulatory restrictions.

EU: Roche Drug for Kidney Disease OK’d (AP)Roche Holding AG said Thursday it has won approval from the European Union for use of its anemia drug Mircera in treating patients with chronic kidney disease.

JNJ Stock Investing | Google Finance JNJ | Yahoo Finance JNJ

CEPH Stock Investing

StockBagger Expert — Fri, 27 Jul 2007 13:00:44 +0000

N100 Leaders & Laggards: ISRG TLAB SIRI (AP)The Nasdaq 100 inched up Monday, boosted by the second day of gains for Intuitive Surgical Inc. The Nasdaq 100, which includes 100 of the largest nonfinancial securities listed on the Nasdaq Stock Market, rose 0.45 points to 2,036.33.

Midday Leaders & Laggards: Nasdaq 100 (AP)Shares of communications equipment company Tellabs Inc. rose on buyout speculation in Monday midday trading, helping to send the Nasdaq 100 higher.

Sector Glance: Biotech Stocks Fall (AP)Shares of biotechnology companies traded slightly lower Tuesday on a day of light news, as the sector edges closer to the beginning of its earnings season.

Cephalon Announces Plans for New NDA Filing for TREANDA(R) (PR Newswire)Cephalon, Inc. today announced that, based on data from a European study, it now plans to file in the third quarter of 2007 a new drug application with the U.S. Food and Drug Administration for TREANDA? for the treatment of chronic lymphocytic leukemia .

CEPH Stock Investing | Google Finance CEPH | Yahoo Finance CEPH

GENZ

StockBagger Expert — Fri, 27 Jul 2007 13:00:27 +0000

Earnings Produce a Few Bright Spots (AP)As the stock market endured one of its worst sell-offs of 2007, a few stocks managed to post gains on strong quarterly results.

Ahead of the Bell: Genzyme (AP)Analysts hailed Genzyme Corp.’s drug pipeline Thursday, a day after the biotechnology reported a larger second-quarter profit than analysts expected and also raised its outlook for the year.

N100 Leaders & Laggards: AMZN VRTX GENZ (AP)The Nasdaq 100 rose Wednesday, boosted by a strong second-quarter earnings report from Amazon.com Inc. The Nasdaq 100, which includes 100 of the largest nonfinancial securities listed on the Nasdaq Stock Market, rose 10.59 points to 2,011.14.

Genzyme issues strong earnings report, raises forecast (at MarketWatch)Genzyme Corp. issued a strong second-quarter earnings and sales report on Wednesday, prompting the diversified biotech group to raise its 2007 financial forecast.

GENZ Stock Investing | GENZ>Google Finance GENZ | GENZ>Yahoo Finance GENZ

KMB Stock Investing

StockBagger Expert — Fri, 27 Jul 2007 13:00:23 +0000

Moody’s Cuts Kimberly-Clark Rating (AP)Moody’s Investors Service downgraded Kimberly-Clark Corp.’s senior unsecured rating to “A2″ from “Aa3″ on Tuesday after the maker of Kleenex tissue and Huggies diapers announced a $2 billion accelerated share buyback program.

Fitch Downgrades Kimberly-Clark (AP)Fitch Ratings on Wednesday downgraded the ratings of Kimberly-Clark Corp., saying the personal care product maker’s planned share buyback will significantly increase debt and put its credit at risk.

Kimberly-Clark earnings up 22%; forecast raised for 2007 (at MarketWatch)Kimberly-Clark Corp., maker of Kleenex tissue and Kotex sanitary pads, reported Tuesday that second-quarter profit jumped 22%, lifted by new Huggies diapers and gains in emerging markets such as China and Russia.

Sector Wrap: Consumer Products Makers (AP)Consumer products makers were fairly stable Thursday, even as the markets suffered a steep drop. The Dow Jones industrial average fell 2.3 percent, the Standard and Poor’s 500 shed 2.3 percent, and the Nasdaq 100 dipped 1.2 percent.

KMB Stock Investing | Google Finance KMB | Yahoo Finance KMB

BTE-UN.TO Stock Investing

StockBagger Expert — Fri, 27 Jul 2007 13:00:16 +0000

Stock Investing | Google Finance | Yahoo Finance

DNA Stock Investing

StockBagger Expert — Fri, 27 Jul 2007 12:46:40 +0000

Sector Glance: Biotechnology (AP)Shares of biotechnology companies closed mainly lower Thursday despite positive earnings from Celgene Corp., as the overall market took its biggest fall of the year on concerns over mortgage and corporate lending.

Biogen Idec Swings to 2Q Profit (AP)Biogen Idec Inc. said Tuesday it swung to a second-quarter profit on strong sales of two key drugs, and the biotechnology firm raised its financial expectations for the year.

Biogen Idec swings to quarterly profit as revenue rises 17% (at MarketWatch)Biogen Idec Inc. reported Tuesday improved second-quarter financial results, due to both strong product sales and hefty merger-related charges taken against results for the year-ago period.

Earnings Preview: Biogen Idec (AP)Biogen Idec Inc. reports earnings for the second quarter on Tuesday. The following is a summary of key developments and analyst opinion related to the period.

OSI Pharmaceuticals Slips on Sell Call (AP)Shares of OSI Pharmaceuticals Inc., which is the international partner of Roche Holding AG, slipped Friday after a JPMorgan analyst reiterated an “Underweight” rating on the stock, citing flat U.S. sales of cancer drug Tarceva.

DNA Stock Investing | Google Finance DNA | Yahoo Finance DNA

CL Stock Investing

StockBagger Expert — Fri, 27 Jul 2007 12:46:32 +0000

Colgate-Palmolive Q2 Profit Up (AP)Colgate-Palmolive Co. said Wednesday its second-quarter profit rose 47 percent as it improved profit margins, cut costs and carved out market share through record spending on advertising.

Wall St rises on upbeat earnings (FT.com)Wall Street stocks rose in early trading on Wednesday as investors responded to generally upbeat company earnings from companies including Amazon and digested fresh housing data.

Wall St higher in volatile session (FT.com)Wall Street stocks closed higher on Wednesday as investors responded to generally upbeat company earnings from companies including Amazon and Boeing and got to grips with fresh housing market data.

S&P, Nasdaq slip in volatile session (FT.com)Wall Street stocks turned mixed in afternoon trading on Wednesday as investors responded to generally upbeat company earnings from companies including Amazon and Boeing and got to grips with fresh housing market data.

Colgate-Palmolive’s profit sparkles from new products (at MarketWatch)Colgate-Palmolive Co. reported on Wednesday that second-quarter profit surged 47%, as record advertising spending helped drive sales of Colgate Total Advanced Clean toothpaste and other new products.

CL Stock Investing | Google Finance CL | Yahoo Finance CL

FNM Stock Investing

StockBagger Expert — Fri, 27 Jul 2007 12:46:29 +0000

Stock Investing | Google Finance | Yahoo Finance

PFE Stock Investing

StockBagger Expert — Fri, 27 Jul 2007 12:46:24 +0000

Bristol-Myers, AstraZeneca Profits Mixed (AP)A slim sales increase helped boost Bristol-Myers Squibb Co.’s second-quarter profit but a 10 percent sales jump wasn’t enough to keep AstraZeneca PLC’s profit from falling as it increases layoffs to cut costs.

Sector Snap: Drug Companies (AP)U.S. shares of GlaxoSmithKline PLC rose Wednesday on a buyback announcement that offset disappointing earnings news, while other companies in the sector were mixed.

Biotech Stocks: GlaxoSmithKline, Genzyme push sector benchmarks higher (at MarketWatch)Pharmaceutical and biotechnology stocks rallied Wednesday, after GlaxoSmithKline PLC announced plans to buy back up to $25 billion in stock and Genzyme Corp. reported strong second-quarter earnings.

Hydra Biosciences inks $195M deal with Pfizer (bizjournals.com)Hydra Biosciences Inc. said Thursday the company has signed a collaborative agreement with Pfizer Inc. to develop pain medication using its “transient receptor potential” technology.

Ranbaxy, GlaxoSmithKline Settle Dispute (AP)Indian generic drugmaker Ranbaxy Laboratories Ltd. said Thursday it has reached an agreement with GlaxoSmithKline PLC to settle their dispute over a U.S. patent covering the British company’s herpes pill Valtrex.

Nigeria Court Case Vs. Pfizer Delayed (AP)A Nigerian judge has delayed criminal proceedings against pharmaceutical giant Pfizer Inc. until October to allow prosecutors more time to prepare, court officials said Wednesday.

PFE Stock Investing | Google Finance PFE | Yahoo Finance PFE

BP Stock Investing

StockBagger Expert — Fri, 27 Jul 2007 12:46:09 +0000

Russia Expels UK Economic Official (AP)The head of the British Embassy’s economic section was one of four diplomats told to leave Russia in the tit-for-tat diplomatic expulsions that have followed the poisoning of Kremlin critic Alexander Litvinenko in London, people familiar with the situation said Thursday.

ConocoPhillips Profit Down 94 Pct. in 2Q (AP)ConocoPhillips’ decision to snub an invitation from President Hugo Chavez to keep producing crude oil in Venezuela under tougher terms has had two results: much lower net profit in the second quarter and a projected drop in third-quarter production.

Shell 2Q Net Profit Rises 18 Percent (AP)Royal Dutch Shell PLC said Thursday that its net profit rose 18 percent in the second quarter, thanks to asset sales and strong increases in margins at oil refineries. But the company’s combined gas and oil production dipped.

U.S. Natural Gas in Storage Grows (AP)Natural gas in storage in the U.S. grew last week and remains about 16 percent above the five-year average for this time of year, according to a government report Thursday.

Shell Net Profit Up 18 Percent in 2Q (AP)Royal Dutch Shell PLC said Thursday net profit rose 18 percent in the second quarter, thanks to asset sales and strong increases in margins at oil refineries — but the company’s net gas and oil production dipped.

BP Stock Investing | Google Finance BP | Yahoo Finance BP

MEDI Stock Investing

StockBagger Expert — Fri, 27 Jul 2007 12:46:04 +0000

MedImmune chairman leaves as merger deal closes (bizjournals.com)As a final step in MedImmune’s transformation into a foreign-owned subsidiary, the company’s founder and chairman, Wayne Hockmeyer, announced his retirement.

MedImmune’s ticker symbol about to go dark (bizjournals.com)In the end of an era of sorts for the local biotech community, MedImmune Inc. has filed to delist itself from the stock exchange as an independent company.

Gov’t Awards $132M in Flu Contracts (AP)The federal government on Thursday awarded $132.5 million in contracts to MedImmune and Sanofi Pasteur in order to ramp up their capacity to produce flu vaccines.

Digene sold to Dutch firm for $1.6B (bizjournals.com)Another one of Maryland’s biotech powerhouses is getting gobbled up.

MEDI Stock Investing | Google Finance MEDI | Yahoo Finance MEDI

WFMI Stock Investing

StockBagger Expert — Fri, 27 Jul 2007 12:45:58 +0000

FTC Releases Whole Foods Exhibits (AP)In a lawsuit deposition, the chief executive of Whole Foods Market Inc. made an unapologetic defense of his company’s strategy of buying its rival to eliminate a competitor.

7 Options You Need to Know for Thursday (TradingMarkets.com)Today’s options list includes Baidu.com, Deckers Outdoor, and Southern Copper.

Whole Foods Market, Inc. Announces Third Quarter Earnings Conference Call and Webcast (PR Newswire)Whole Foods Market, Inc. today announced that it will issue financial results for the Company’s third fiscal quarter ended July 1, 2007, after the market closes on Tuesday, July 31, 2007.

Whole Foods Extends Offer for Wild Oats (AP)Whole Foods Market Inc., hoping to salvage the purchase of rival Wild Oats Markets Inc., said Friday it had extended its tender offer for all Wild Oats shares again, to Aug. 10.

WFMI Stock Investing | Google Finance WFMI | Yahoo Finance WFMI